Consensus Fractyl Health, Inc.

Equities

GUTS

US35168W1036

Market Closed - Nasdaq Other stock markets 01:30:00 18/05/2024 am IST			5-day change	1st Jan Change
7.06 ^USD	+5.53%		+14.05%	0.00%

13/05	Earnings Flash (GUTS) FRACTYL HEALTH Reports Q1 Revenue $33,000	MT
13/05	Fractyl Health, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Evolution of the average Target Price on Fractyl Health, Inc.

Price target over the last 5 years

History of analyst recommendation changes

6e73b2dcf9d2f7ecce24.kz7Id2Vw0WNBuMf6DmHARDaIbEuM2m3EmEqO7uL4clo.yw-iIRwmojAM4q2uPBO6PlHuJBq6iVWi0BPChoqIEyDFa6ZBURuDNS7ckg~0d38c179bb5ba715693be233fe1c0357

Analyst Recommendations on Fractyl Health, Inc.

Evercore ISI Initiates Fractyl Health at Outperform Rating	28/02	MT
BofA Securities Initiates Fractyl Health at Buy Rating With $26 Price Target	27/02	MT
Morgan Stanley Initiates Fractyl Health at Overweight Rating With $18 Price Target	27/02	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

7.06 USD

Average target price

22 USD

Spread / Average Target

+211.61%

High Price Target

26 USD

Spread / Highest target

+268.27%

Low Price Target

18 USD

Spread / Lowest Target

+154.96%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Fractyl Health, Inc.

Evercore ISI
BofA Securities
Morgan Stanley

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar